{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:12:27Z","timestamp":1758636747599},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1007\/bf01703233","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:14:12Z","timestamp":1118538852000},"page":"181-184","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor"],"prefix":"10.1007","volume":"66","author":[{"given":"W.","family":"Schwinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01703233_CR1","first-page":"501","volume":"300","author":"A Bacigalupo","year":"1979","unstructured":"Bacigalupo A, Giordano D, Van Lint MT, Vimercati R, Marmont AM (1979) Bolus methylprednisolone in severe aplastic anemia. N Engl J Med 300: 501\u2013502","journal-title":"N Engl J Med"},{"key":"BF01703233_CR2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM197612302952708","volume":"295","author":"DT Baran","year":"1976","unstructured":"Baran DT, Gruner PF, Klemperer MR (1976) Recovery from aplastic anemia after treatment with cyclophosphamide. N Engl J Med 295: 1522\u20131523","journal-title":"N Engl J Med"},{"key":"BF01703233_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2008-1033704","volume":"200","author":"St Burdach","year":"1988","unstructured":"Burdach St, Zessack N, Levitt L (1988) Molecular mechanisms of cellular interaction in immunoregulation of erythropoiesis. Klin Paediatr 200: 165\u2013172","journal-title":"Klin Paediatr"},{"key":"BF01703233_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3476(82)80662-8","volume":"100","author":"MS Cairo","year":"1982","unstructured":"Cairo MS, Baehner RL (1982) The use of antithymocyte globulin in the treatment of severe aplastic anemia in children: Pediatr 100: 307\u2013311","journal-title":"Pediatr"},{"key":"BF01703233_CR5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0308-2261(21)00051-5","volume":"7","author":"BM Camitta","year":"1979","unstructured":"Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R (1979) Severe aplastic anemia: a prospective study of the effect of androgens or transplantation on hematological recovery and survival. Clin Haematol 7: 587\u2013595","journal-title":"Clin Haematol"},{"key":"BF01703233_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJM198301203080301","volume":"308","author":"R Champlin","year":"1983","unstructured":"Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: prospective randomized trial. N Engl J Med 308: 113\u2013118","journal-title":"N Engl J Med"},{"key":"BF01703233_CR7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood.V63.2.342.342","volume":"63","author":"K Doney","year":"1984","unstructured":"Doney K, Dahlberg SJ, Monroe D, Storb R, Buckner CD, Thomas ED (1984) Therapy of severe aplastic anemia with antihuman thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion. Blood 63: 342\u2013348","journal-title":"Blood"},{"key":"BF01703233_CR8","first-page":"239","volume":"15","author":"K Doney","year":"1987","unstructured":"Doney K, Storb R, Buckner CD, et al. (1987) Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 15: 239\u2013242","journal-title":"Exp Hematol"},{"key":"BF01703233_CR9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","volume":"324","author":"N Frickhofen","year":"1988","unstructured":"Frickhofen N, Kaltwasser JP, for the German Study Group Aplastic Anemia (1988) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324: 1297\u20131304","journal-title":"N Engl J Med"},{"key":"BF01703233_CR10","first-page":"2597","volume":"19","author":"E Gluckmann","year":"1987","unstructured":"Gluckmann E (1987) Current status of bone marrow transplantation for severe aplastic anemia: a preliminary report from the international Bone Marrow Transplant Registry. Transplant Proc 19: 2597\u20132599","journal-title":"Transplant Proc"},{"key":"BF01703233_CR11","unstructured":"Herve P, Cahn JY (1989) Placebo-controlled double-blind study for evaluation of effectivness of anti IL-2-receptor monoclonal antibody in acute graft-versus-host disease after allogeneic bone marrow transplantation. Study protocol."},{"key":"BF01703233_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM197701062960103","volume":"296","author":"R Hoffman","year":"1977","unstructured":"Hoffman R, Zanjani ED, Lutton JD, Zalusky R, Wassermann LR (1977) Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med 296: 10\u201313","journal-title":"N Engl J Med"},{"key":"BF01703233_CR13","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.83.23.9026","volume":"83","author":"S Kondo","year":"1986","unstructured":"Kondo S, Shimuzu A, Saito Y, Kinoshita M, Honjo T (1986) Molecular basis for two different affinity states of the inter-leukin-2 receptor: affinity conversion model. Proc Natl Acad Sci USA 83: 9026\u20139029","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01703233_CR14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V70.5.1325.1325","volume":"70","author":"PB McGlave","year":"1987","unstructured":"McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NK (1987) Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 70: 1325\u20131330","journal-title":"Blood"},{"key":"BF01703233_CR15","first-page":"7","volume":"9","author":"MAS Moore","year":"1990","unstructured":"Moore MAS (1990) Hematopoietic growth factor interactions: in vitro and in vivo preclinical evaluation. Cancer Surv 9: 7\u201378","journal-title":"Cancer Surv"},{"key":"BF01703233_CR16","first-page":"51","volume":"5","author":"LL Sensenbrenner","year":"1977","unstructured":"Sensenbrenner LL, Steele AA, Santos GW (1977) Recovery of hematologic compentence without engraftment following attempted bone marrow transplantation for aplastic anemia; report of a case with diffusion chamber studies. Exp Hematol 5: 51\u201358","journal-title":"Exp Hematol"},{"key":"BF01703233_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM198403083101013","volume":"310","author":"PA Stryckmans","year":"1984","unstructured":"Stryckmans PA, Dumont JP, Velu T, Debusscher L (1984) Cyclosporine in refractory severe aplastic anemia. N Engl J Med 310: 655\u2013656","journal-title":"N Engl J Med"},{"key":"BF01703233_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1977.tb00653.x","volume":"36","author":"MC Territo","year":"1977","unstructured":"Territo MC, for the UCLA Bone Marrow Transplantation Team (1977) Autologous bone marrow repopulation following high-dose cyclophosphamide and allogeneic marrow transplantation in aplastic anemia. Br J Haematol 36: 305\u2013312","journal-title":"Br J Haematol"},{"key":"BF01703233_CR19","first-page":"97","volume":"4","author":"ED Thomas","year":"1976","unstructured":"Thomas ED, Storb R, Giblett ER, et al. (1976) Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 4: 97\u2013102","journal-title":"Exp Hematol"},{"key":"BF01703233_CR20","first-page":"225","volume":"96","author":"CH Urban","year":"1984","unstructured":"Urban CH, Zoubek A, Krottmayer G, Slave I, Kaulfersch N, Wagner K (1984) Immunosuppressive treatment of SAA with high-dose methylprednisolone and antithymocyte globulin in two patients. Wien Klin Wochenschr 96: 225\u2013230","journal-title":"Wien Klin Wochenschr"},{"key":"BF01703233_CR21","first-page":"327","volume":"2","author":"PI Warkentin","year":"1980","unstructured":"Warkentin PI, Ramsay NK, Krivit W, Coccia PF, Nesbit MF, Condie R, Kersey JH (1980) Aplastic anemia, continued: immunosuppressive therapy for severe aplastic anemia. Am J Pediatr Hematol Oncol 2: 327\u2013338","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BF01703233_CR22","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1182\/blood.V72.6.1861.1861","volume":"72","author":"N Young","year":"1988","unstructured":"Young N, Griffith P, Brittain E, et al. (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72: 1861\u20131869","journal-title":"Blood"},{"key":"BF01703233_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198501313120501","volume":"312","author":"NC Zoumbos","year":"1985","unstructured":"Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS (1985) Circulating activated suppressor T-lymphocytes in aplastic anemia. N Engl J Med 312: 257\u2013265","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703233\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T18:09:29Z","timestamp":1626026969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["BF01703233"],"URL":"https:\/\/doi.org\/10.1007\/bf01703233","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}